[Form 4] Zoetis Inc. Insider Trading Activity

Rhea-AI Filing Summary

Roxanne Lagano, Executive Vice President of Zoetis Inc. (ZTS), reported a charitable gift of 700 shares of Zoetis common stock on 09/15/2025. The transaction is coded as a gift and carried no price. After the gift, Ms. Lagano directly beneficially owns 14,429 shares. She also holds the equivalent of 819.698 shares indirectly through the Zoetis Savings Plan (401(k)) as of June 30, 2025. The Form 4 was signed by an attorney-in-fact on 09/16/2025. The filing provides ownership levels and documents the charitable disposition; no option or derivative activity is reported.

Insights

Corporate Governance Expert

TL;DR: Insider reported a small charitable gift; disclosure shows routine compliance with Section 16 reporting requirements.

The Form 4 documents a 700-share gift to a donor-advised fund and updates direct and indirect beneficial ownership. This is an administrative disclosure rather than a market-moving transaction. It demonstrates adherence to reporting rules and transparency about executive holdings. No sales or derivatives are recorded, and the remaining direct holding of 14,429 shares combined with 401(k) equivalents is clearly stated.

Securities Analyst

TL;DR: The transfer is immaterial to Zoetis’ capitalization; it is a charitable disposition with no proceeds and limited investor impact.

The transaction code (G) indicates a gift; price is not applicable. The filing includes the precise 401(k) share equivalent (819.698) as of June 30, 2025, which helps reconcile total insider exposure. Given the small size relative to company float, there is no immediate implication for liquidity or valuation from this disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lagano Roxanne

(Last) (First) (Middle)

C/O ZOETIS INC.

10 SYLVAN WAY

(Street)

PARSIPPANY NJ 07054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		G		700(1)	D	$0(2)	14,429	D
Common Stock								819.698(3)	I	401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the gift of common stock to a charitable donor advised fund.

2. Price not applicable to gift.

3. Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of June 30, 2025.

Remarks:

	/s/ Brenda Santuccio, as Attorney-in-Fact	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.